CADTH at ISPOR 2015

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is an authority on outcomes research that aims to improve health care decisions and health, globally.

CADTH is a regular participant at ISPOR, and this year we're proud to be presenting on topics related to health economics, health policy development using outcomes research issues, and the cost-effectiveness of drugs for pulmonary arterial hypertension.

If you're attending ISPOR 2015, join us at one of the sessions listed below. You can also follow the hashtag #ISPORPhila on Twitter.

Can the EUnetHTA HTA Core Model© Help to Ensure an Aligned Concept of Value Between HTA, Decision-Makers/Payers, and Pharma Industry? (Issue Panel)

Date:    Tuesday, May 19, 2015 (Grand Ballroom, Salon C, D, E)
Time:   2:15 p.m. to 3:15 p.m.

Moderator

• Finn Boerlum Kristensen, PhD, Secretariat Director, Danish Health and Medicines Authority, Denmark

Panellists

• Melvin Olson, PhD, Executive Director HEOR, Novartis Pharma, Switzerland
• David Shum, PhD, Head, Market Access, F. Hoffmann La Roche, Canada
• Chander Sehgal, MD, MBA, Director, CADTH Common Drug Review & Optimal Use of Drugs, CADTH, Canada

A Review and Update to the Guidance Document for the Costing Process in the Canadian Health Care Setting (Presentation)

Date:    Monday, May 18, 2015 (Grand Ballroom, Salon H)
Time:   4:30 p.m. to 4:45 p.m.

Cost-Effectiveness of Drugs for Pulmonary Arterial Hypertension: A Canadian Study (Poster)

Date:    Monday, May 18 and Tuesday May 19, 2015 (Franklin Hall L4)
Time:   Posters are presented during ISPOR receptions and breaks